Cargando…
Treatment of fungal myositis with intra-lesional and intravenous itraconazole: a case report
INTRODUCTION: Fungal myositis is very uncommon, even in patients who are immunocompromised. Because of its rarity and a lack of clinical experience, no consensus has been reached about the best means of treating fungal myositis. To the best of our knowledge this is the first description of the treat...
Autores principales: | Lin, Xiao-Ji, Yao, Rong-Xin, He, Mu-Qing, Zhu, Bao-Ling, Guo, Wen-Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668258/ https://www.ncbi.nlm.nih.gov/pubmed/23683326 http://dx.doi.org/10.1186/1752-1947-7-132 |
Ejemplares similares
-
Intravenous-oral itraconazole versus oral posaconazole in preventing invasive fungal diseases for acute leukemia patients
por: Liu, Li, et al.
Publicado: (2023) -
Functional Nanocarriers for Delivering Itraconazole Against Fungal Intracellular Infections
por: Mejía, Susana P., et al.
Publicado: (2021) -
Study on Formulation, in vivo Exposure, and Passive Targeting of Intravenous Itraconazole Nanosuspensions
por: Yuan, Qi, et al.
Publicado: (2019) -
Trismus originating from rare fungal myositis in pterygoid muscles: A case report
por: Bi, Ling, et al.
Publicado: (2021) -
Drug susceptibility in emerging fungal infections: tests with
fluconazole, itraconazole, and amphotericin B
por: Fay, Vanessa da Silva, et al.
Publicado: (2018)